AJP - Heart and Circulatory Physiology, Vol 272, Issue 1 57-H66, Copyright © 1997 by American Physiological Society

ARTICLES

Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart

J. M. Harrer, K. Haghighi, H. W. Kim, D. G. Ferguson and E. G. Kranias
Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Ohio 45267, USA.

Phospholamban, the regulator of Ca(2+)-adenosinetriphosphatase (ATPase) activity in cardiac sarcoplasmic reticulum (SR), is an important determinant of basal myocardial performance. To determine whether phospholamban expression is developmentally regulated in the mouse and whether such regulation reflects alterations in Ca2+ pump activity, hearts from different stages of development were processed for molecular biological and biochemical studies. Both phospholamban and Ca(2+)-ATPase mRNAs were approximately 40% of adult (100%) levels at birth and gradually increased to approach adult levels by day 15 of development. These changes in transcript levels were indicative of changes at the protein level for both phospholamban and Ca(2+)-ATPase. Analysis of the initial rates of Ca2+ uptake demonstrated that over the course of development the upregulation of Ca(2+)-ATPase correlated with increases in the maximal rates of Ca2+ uptake and the constant apparent stoichiometric ratio of phospholamban to Ca(2+)-ATPase correlated with maintenance of a constant affinity of this enzyme for Ca2+ (0.25 +/- 0.03 microM Ca2+). Furthermore, targeted ablation of phospholamban in the mouse resulted in a much higher affinity of Ca2+ uptake for Ca2+ (0.10 +/- 0.02 microM Ca2+) than that observed in wild-type hearts, and this increased affinity was also maintained across different stages of postnatal development. These findings suggest that phospholamban is a major regulator of the affinity of Ca(2+)-ATPase for Ca2+, and coordinate regulation of the expression levels of these two SR proteins may be necessary for maintaining Ca2+ homeostasis in the developing mammalian heart.

This article has been cited by other articles:

				J. Huang, L. Hove-Madsen, and G. F. Tibbits SR Ca2+ refilling upon depletion and SR Ca2+ uptake rates during development in rabbit ventricular myocytes Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1906 - C1915. [Abstract] [Full Text] [PDF]

				Y.-Q. Zhou, F. S. Foster, R. Parkes, and S. L. Adamson Developmental changes in left and right ventricular diastolic filling patterns in mice Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1563 - H1575. [Abstract] [Full Text] [PDF]

				A. G. Brittsan, A. N. Carr, A. G. Schmidt, and E. G. Kranias Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban J. Biol. Chem., April 14, 2000; 275(16): 12129 - 12135. [Abstract] [Full Text] [PDF]

				H. He, M. Meyer, J. L. Martin, P. M. McDonough, P. Ho, X. Lou, W. Y. W. Lew, R. Hilal-Dandan, and W. H. Dillmann Effects of Mutant and Antisense RNA of Phospholamban on SR Ca2+-ATPase Activity and Cardiac Myocyte Contractility Circulation, August 31, 1999; 100(9): 974 - 980. [Abstract] [Full Text] [PDF]

				Y. Ji, E. Loukianov, T. Loukianova, L. R. Jones, and M. Periasamy SERCA1a can functionally substitute for SERCA2a in the heart Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H89 - H97. [Abstract] [Full Text] [PDF]

				E. Loukianov, Y. Ji, I. L. Grupp, D. L. Kirkpatrick, D. L. Baker, T. Loukianova, G. Grupp, J. Lytton, R. A. Walsh, and M. Periasamy Enhanced Myocardial Contractility and Increased Ca2+ Transport Function in Transgenic Hearts Expressing the Fast-Twitch Skeletal Muscle Sarcoplasmic Reticulum Ca2+-ATPase Circ. Res., November 2, 1998; 83(9): 889 - 897. [Abstract] [Full Text] [PDF]

				W. Chen, R. London, E. Murphy, and C. Steenbergen Regulation of the Ca2+ Gradient Across the Sarcoplasmic Reticulum in Perfused Rabbit Heart : A 19F Nuclear Magnetic Resonance Study Circ. Res., November 2, 1998; 83(9): 898 - 907. [Abstract] [Full Text] [PDF]

				Y. Sato, D. G. Ferguson, H. Sako, G. W. Dorn II, V. J. Kadambi, A. Yatani, B. D. Hoit, R. A. Walsh, and E. G. Kranias Cardiac-specific Overexpression of Mouse Cardiac Calsequestrin Is Associated with Depressed Cardiovascular Function and Hypertrophy in Transgenic Mice J. Biol. Chem., October 23, 1998; 273(43): 28470 - 28477. [Abstract] [Full Text] [PDF]

				I. Gombosova, P. Boknik, U. Kirchhefer, J. Knapp, H. Luss, F. U. Muller, T. Muller, U. Vahlensieck, W. Schmitz, G. S. Bodor, et al. Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H2123 - H2132. [Abstract] [Full Text] [PDF]